Leading Femtech Brand INNOVO Attracts Two New Investors
News provided by
Share this article
Share this article
INNOVO adds significant incremental investment for pioneering home-based treatment for stress urinary incontinence, a condition that impacts 1 in 3 women worldwide
Netherland s Borski Fund backs female-led, femtech focused companies
Largest single investment Ireland s Western Development Commission has made to date
Financing will support the expansion of Atlantic Therapeutics commercialization activities into their core US & UK markets & beyond
GALWAY, Ireland, March 8, 2021 /PRNewswire/ Atlantic Therapeutics, the Galway-based company pioneering a non-invasive, wearable treatment for urinary incontinence, today announced it has raised significant new investment from the Borski Fund (Netherlands) and the Western Development Commission (Ireland).
25 Feb 2021 : News Desk CREW Chief Executive Niamh Costello Creative Enterprise West (CREW) is a brand-new collaborative initiative, which supports the creative digital enterprise sector in the West.
Key partners in the dynamic CREW initiative are the Galway-Mayo Institute of Technology (GMIT), the Western Development Commission (WDC), and the Galway Film Centre (GFC).
CREW has appointed Niamh Costello formerly of Galway Technology Centre as Chief Executive.
CREW’s focus will be on the development and scaling of creative digital entrepreneurs, job creation, incubation, and accelerator programmes, training, and outreach services along the Atlantic Economic Corridor. Plans are also underway for the development of a Centre of Excellence providing enterprise and co-working space, on the GMIT Centre for Creative Arts & Media, Cluain Mhuire campus, Galway.
Galway Bay FM
16 February 2021
Anthony Cheung, VP of Finance, Atlantic Therapeutics and Gillian Buckley, Investment Manager at WDC
Largest single investment the Western Development Commission has made to date
Financing will support the expansion of Atlantic Therapeutics commercialization activities from their Co. Galway base. Â
Technology is used to treat urinary incontinence that impacts 1 in 3 women worldwideÂ
Â
Â
Atlantic Therapeutics, the Galway-based company pioneering a non-invasive, wearable treatment for urinary incontinence, today announced it has raised Â2 million from The Western Development CommissionÂs investment fund.Â
This is the largest single investment the WDC Investment Fund have made to date and is complemented by returning investors Seroba Life Sciences, Earlybird, LSP, Andera Partners and Atlantic Bridge, who continue their ongoing support for Atlantic Therapeutics with a substantial u
Sharp decline in early-stage Irish start-up funding deals in 2020
Gillian Buckley, chair of the IVCA. Image: IVCA
New figures from the Irish Venture Capital Association show that investors put money in safer bets during the pandemic.
Venture capital funding in early-stage start-ups in Ireland fell by almost a third in 2020 as the pandemic downturn took its toll on deal making.
While overall funding figures are up – with €925m invested in Irish SMEs last year compared to €820m the year prior – investments in early-stage start-ups dropped 32pc, from €285m to €194m. That’s according to the new figures from the Irish Venture Capital Association (IVCA), which deems an early-stage start-up deal to be €5m or less.